Cargando…
Complete response of metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus cabozantinib
INTRODUCTION: The effectiveness of nivolumab plus cabozantinib for metastatic papillary renal cell carcinoma with inferior vena cava tumor thrombus remains unclear. CASE PRESENTATION: A 77‐year‐old male was diagnosed with right papillary renal cell carcinoma with a metastatic lesion on Gerota's...
Autores principales: | Hayashida, Michikata, Miura, Yuji, Yamaguchi, Takeshi, Tanaka, Makoto, Yamanaka, Taro, Takemura, Kohji, Oka, Suguru, Sakaguchi, Kazushige, Ito, Shinji, Urakami, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622194/ https://www.ncbi.nlm.nih.gov/pubmed/37928303 http://dx.doi.org/10.1002/iju5.12638 |
Ejemplares similares
-
Complete response of metastatic renal cell carcinoma with inferior vena cava tumor thrombus to nivolumab plus ipilimumab
por: Hayashida, Michikata, et al.
Publicado: (2022) -
A risk model for detecting clinically significant prostate cancer based on bi-parametric magnetic resonance imaging in a Japanese cohort
por: Sakaguchi, Kazushige, et al.
Publicado: (2021) -
First case report of robot‐assisted radical cystectomy for bladder cancer that developed after salvage radiotherapy following radical prostatectomy for prostate cancer
por: Oka, Suguru, et al.
Publicado: (2023) -
Bell's palsy during rechallenge of immune checkpoint inhibitor
por: Takemura, Kohji, et al.
Publicado: (2023) -
The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening
por: Oka, Suguru, et al.
Publicado: (2023)